CNS vs CVBF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

CNS

59.9
AI Score
VS
CNS Wins

CVBF

49.2
AI Score

Investment Advisor Scores

CNS

60score
Recommendation
HOLD

CVBF

49score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CNS CVBF Winner
Forward P/E 18.4502 11.534 CVBF
PEG Ratio 1.6881 1.4662 CVBF
Revenue Growth 12.2% 42.0% CVBF
Earnings Growth 31.9% -21.6% CNS
Tradestie Score 59.9/100 49.2/100 CNS
Profit Margin 28.8% 36.1% CVBF
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CNS 1M: -5.6% · 3M: -6.9% CVBF 1M: -0.5% · 3M: -2.6%

Current Technical Phase

CNS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.8%), weak momentum, RSI 36

RSI (14): 36.2 · Price: $73.12

CVBF

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -0.4%) with fading momentum, RSI 47

RSI (14): 47.4 · Price: $22.17

Fundamentals Snapshot

Metric CNS CVBF
Market Cap — —
Forward P/E 18.4 11.0
Trailing P/E 22.4 15.0
Revenue (TTM) — —
Revenue Growth 0.1% 0.4%
Gross Margin 0.5% 1.0%
Operating Margin 0.3% 0.6%
EPS 3.26 1.44
Dividend Yield 0.04% 0.04%

Frequently Asked Questions

Based on our detailed analysis, CNS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.